112888-43-4

Basic information

• Product Name: 6-Bromomethyl-3,4-dihydro-2-methyl-quinazolin-4-one
• Synonyms: 6-(BROMOMETHYL)-2-METHYL-4(1H)-QUINAZOLINONE;6-BROMOMETHYL-3,4-DIHYDRO-2-METHYL QUINAZOLIN-4-ONE;4,6-(Bromomethyl)-2-Methy Quinazolinone;6-(Bromomethyl)-2-methyl-4(3H)-quinazolinone;6-Bromomethyl-3,4-dihydro-2-methylquinazoline-4-one;6-Bromomethyl-3,4-dihydro-2-methyl-quizolin-4-one;4(3H)-Quinazolinone,6-(bromomethyl)-2-methyl-
• CAS NO: 112888-43-4
• Molecular Formula: C₁₀H₉BrN₂O
• Molecular Weight: 253.1
• Product Categories: Heterocyclic Compounds;Heterocycles;Intermediates;Intermediates & Fine Chemicals;Pharmaceuticals;Raltitrexed
• Mol File: 112888-43-4.mol
• Article Data: 10

Chemical Properties

• Melting Point: >330 °C(Solv: chloroform (67-66-3))
• Boiling Point: 399.387 °C at 760 mmHg
• Flash Point: 195.342 °C
• Appearance: /
• Density: 1.634 g/cm³
• Vapor Pressure: 1.37E-06mmHg at 25°C
• Refractive Index: 1.669
• Storage Temp.: under inert gas (nitrogen or Argon) at 2-8°C
• PKA: 2.21±0.20(Predicted)
• CAS DataBase Reference: 6-Bromomethyl-3,4-dihydro-2-methyl-quinazolin-4-one(CAS DataBase Reference)
• NIST Chemistry Reference: 6-Bromomethyl-3,4-dihydro-2-methyl-quinazolin-4-one(112888-43-4)
• EPA Substance Registry System: 6-Bromomethyl-3,4-dihydro-2-methyl-quinazolin-4-one(112888-43-4)

Safety Data

• Hazardous Substances Data: 112888-43-4(Hazardous Substances Data)

Usage

Chemical Properties

off-white powder

Uses

Raltitrexed intermediate

InChI:InChI=1/C10H9BrN2O/c1-6-12-9-3-2-7(5-11)4-8(9)10(14)13-6/h2-4H,5H2,1H3,(H,12,13,14)

Upstream product

• 18731-19-6 3,4-dihydro-2,6-dimethyl-4-oxoquinazoline 
• 62175-49-9 2-methyl-6-methyl-4H-3,1-benzoxazin-4-one 
• 67081-68-9 2-acetamido-5-methylbenzoic acid 
• 7471-58-1 quinazolin-2-one 
• 1082727-34-1 3,4 dihydro-2,6 dimethylquinazolin 
• 128-08-5 N-Bromosuccinimide 
• 72755-11-4 N-methoxy-3-methylbenzamide 
• 99-04-7 m-Toluic acid 
• 2941-78-8 2-Amino-5-methylbenzoic acid 

Downstream Products

• 130379-63-4 diethyl N-<4--N-methylamino>benzoyl>-L-glutamate 
• 129175-88-8 methyl 4--N-prop-2-ynylamino>-2-nitrobenzoate 
• 129175-38-8 (S)-2-{2-Fluoro-4-[methyl-(2-methyl-4-oxo-3,4-dihydro-quinazolin-6-ylmethyl)-amino]-benzoylamino}-pentanedioic acid diethyl ester 
• 130379-67-8 (S)-2-{4-[(2-Bromo-ethyl)-(2-methyl-4-oxo-3,4-dihydro-quinazolin-6-ylmethyl)-amino]-benzoylamino}-pentanedioic acid diethyl ester 
• 129175-44-6 (S)-2-{3-Fluoro-4-[methyl-(2-methyl-4-oxo-3,4-dihydro-quinazolin-6-ylmethyl)-amino]-benzoylamino}-pentanedioic acid diethyl ester 
• 129175-58-2 (S)-2-{4-[Ethyl-(2-methyl-4-oxo-3,4-dihydro-quinazolin-6-ylmethyl)-amino]-2-methoxy-benzoylamino}-pentanedioic acid diethyl ester 
• 129175-45-7 (S)-2-{4-[Ethyl-(2-methyl-4-oxo-3,4-dihydro-quinazolin-6-ylmethyl)-amino]-3-fluoro-benzoylamino}-pentanedioic acid diethyl ester 
• 129175-39-9 (S)-2-{4-[Ethyl-(2-methyl-4-oxo-3,4-dihydro-quinazolin-6-ylmethyl)-amino]-2-fluoro-benzoylamino}-pentanedioic acid diethyl ester 
• 129175-49-1 (S)-2-{2-Chloro-4-[ethyl-(2-methyl-4-oxo-3,4-dihydro-quinazolin-6-ylmethyl)-amino]-benzoylamino}-pentanedioic acid diethyl ester 
• 129175-50-4 (S)-2-{2-Methyl-4-[(2-methyl-4-oxo-3,4-dihydro-quinazolin-6-ylmethyl)-prop-2-ynyl-amino]-benzoylamino}-pentanedioic acid diethyl ester 
• 129175-40-2 (S)-2-{4-[Allyl-(2-methyl-4-oxo-3,4-dihydro-quinazolin-6-ylmethyl)-amino]-2-fluoro-benzoylamino}-pentanedioic acid diethyl ester 
• 129193-67-5 (S)-2-{3-Fluoro-4-[(2-methyl-4-oxo-3,4-dihydro-quinazolin-6-ylmethyl)-prop-2-ynyl-amino]-benzoylamino}-pentanedioic acid diethyl ester 
• 129193-65-3 (S)-2-{2-Fluoro-4-[(2-fluoro-ethyl)-(2-methyl-4-oxo-3,4-dihydro-quinazolin-6-ylmethyl)-amino]-benzoylamino}-pentanedioic acid diethyl ester 
• 129175-57-1 diethyl N-<4--N-prop-2-ynylamino>-2-methoxybenzoyl>-L-glutamate 

Relevant articles and documents

Synthesis of substituted benzylamino- and heterocyclylmethylamino carbodithioate derivatives of 4-(3H)-quinazolinone and their cytotoxic activity

A new series of substituted benzylamino- and heterocyclylmethylamino carbodithioate derivatives of 4-(3H)-quinazolinone were synthesized via four steps starting from 2-amino-5-methyl-benzoic acid and initially screened against A-549 (human non-small cell

Synthesis and in vitro antitumor activity of 4(3H)-quinazolinone derivatives with dithiocarbamate side chains

A series of 4(3H)-quinazolinone derivatives with dithiocarbamate side chains were synthesized and tested for their in vitro antitumor activity against human myelogenous leukemia K562 cells. Among them, (3,4-dihydro-2-methyl-4- oxoquinazolin-6-yl)methyl 4-(4-fluorophenyl)piperazine-1-carbodithioate 8q exhibited significant inhibitory activity against K562 cells with IC 50 value of 0.5 μM.

Cp?CoIII-catalyzed formal [4+2] cycloaddition of benzamides to afford quinazolinone derivatives

A Cp?CoIII-catalyzed arene C-H bond amidation/annulation of benzamides was developed to afford quinazolinone derivatives in one-pot with high yields and broad substrate scope. This method could be applied to the synthesis of quinazolinone drugs and late-stage modification of natural products.